News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Pablo Sanchis: How the Bone Tumor Microenvironment Drives Osteopontin Expression in Metastatic Prostate Cancer
Pablo Sanchis/X
Aug 9, 2025, 10:22

Pablo Sanchis: How the Bone Tumor Microenvironment Drives Osteopontin Expression in Metastatic Prostate Cancer

Pablo Sanchis, Postdoctoral Intern at MD Anderson Cancer Center, shared a post on X he and colleagues co-authored:

“Check out our work Oncogene unveiling how the bone TME drives Osteopontin expression in metastatic prostate cancer and its association with resistance to AR signaling blockade.”

Title: PKA-driven SPP1 activation as a novel mechanism connecting the bone microenvironment to prostate cancer progression

Authors: Pablo Sanchis, Agustina Sabater, Julia Lechuga, Jimena Rada, Rocio Seniuk, Gaston Pascual, Mora Gatti, Juan Bizzotto, Peter D. A. Shepherd, Jun Yang, Javier Cotignola, Elba Vazquez, Joaquin Mateo, Pia Valacco, Estefania Labanca, Christopher Logothetis, Geraldine Gueron, Nicolas Anselmino

Read The Full Article at Oncogene.

Pablo Sanchis: How the Bone Tumor Microenvironment Drives Osteopontin Expression in Metastatic Prostate Cancer

More Posts Featuring Prostate Cancer.

Agustina Sabater cancer Christopher Logothetis Elba Vazquez Estefania Labanca Gaston Pascual Geraldine Gueron Javier Cotignola Jimena Rada Joaquin Mateo Juan Bizzotto Julia Lechuga Jun Yang Mora Gatti Nicolas Anselmino OncoDaily oncogene Oncology Osteopontin Pablo Sanchis. Peter D. A. Shepherd Pia Valacco prostate cancer Rocio Seniuk
Special Coverage
Science
Aug 9, 2025, 11:44
Sylvester Researchers Uncover Molecular Drivers of Cellular Differentiation
Voices
Aug 9, 2025, 11:37
Jasmine Kamboj: How We Bring Ourselves to the Table as Leaders
Voices
Aug 9, 2025, 11:29
Lillian Siu: Registration is Open for the 2025 FDA-AACR-SITC Workshop
Voices
Aug 9, 2025, 11:12
Promising R&D Pipeline Includes 36 Projects in Clinical Development
Insight
Aug 9, 2025, 11:04
A Collaborative Pediatric Cancer Research Awards Program by Rally Foundation
Voices
Aug 9, 2025, 10:59
Mikkael Sekeres: Steps to Avoid Chemicals and How Concerned You Should Be
Voices
Aug 9, 2025, 10:52
Yelena Janjigian: My Mom, a Great Supporter of Science and Cancer Research
Voices
Aug 9, 2025, 10:47
What Do IDH, MGMT, and TERT Have to Do with Brain Tumors? - WeTrials
Voices
Aug 9, 2025, 10:45
Julie S. Torode: Excited to Join World Radiotherapy Awareness Day on September 7
Dialogues
Aug 9, 2025, 10:44
Beyond the Cancer Diagnosis: Interview with Muna Al-Khaifi, by Adrian Pogacian
Science
Aug 9, 2025, 10:40
Ibrahim Halil Sahin: Exclusiveness of BRAF Alterations and HER2 Amplification in Colorectal Cancer
Blog
Aug 9, 2025, 10:38
C Is for Criteria - City Cancer Challenge